Clovis Cancer-Drug Class Action Survives Dismissal Bid
A Colorado federal judge on Thursday refused to dismiss a shareholder putative class action against Clovis Oncology Inc. that claims the drugmaker publicly touted a lung cancer drug it was developing...To view the full article, register now.
Already a subscriber? Click here to view full article